Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component

NCT02164539 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

338

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: FF
DRUG: UMEC
DRUG: VI

Sponsor

GlaxoSmithKline